No Data
No Data
Starlink is rapidly spreading in Brazil.
Space business: Starlink seems to be rapidly spreading in Brazil. Starlink obtained regulatory approval two years ago and became the largest satellite internet communications provider in the country in May of this year. The number of subscribers is currently 0.2 million, and further growth is expected with the introduction of the small antenna 'Starlink Mini'. <7203> Toyota <7721> Tokyo Keiki <2359> Core <3004> Kami-ei <3401> Teijin <34...
While there is active trading in the biotechnology sector, it remains to be seen when investor sentiment will improve.
Improvement in investor sentiment is timely. We hope for a rebound in emerging markets this week after last week's sharp decline, but such improvement may depend on timing. While the opening price of the large cap stock exceeded the offering price, it closed near the lowest of the day, causing concern. The market is following the investment judgment of a large US securities firm with a "buy" rating and coverage beginning at a target stock price of 2,200 yen. It remains to be seen whether the market will regard it as a positive. The company accounted for one-third of the trading value in the growth market over the weekend.
Emerging market prospects: Circulatory selection within the biotechnology sector is booming, but the improvement of investor sentiment depends on timing.
Due to the downturn in high-tech stocks and the appreciation of the yen in the foreign markets, investor sentiment has worsened, leading to a significant drop in the emerging markets this week. During the same period, while the Nikkei Average fell by -5.98%, the growth market index fell by -4.50% and the growth market 250 index fell by -4.86%, experiencing a sharp decline. Like the main board market, investor sentiment has also soured in response to the decline of high-tech stocks and the appreciation of the yen in the foreign markets. This has led to a stronger selling pressure, particularly in bio stocks that had been rapidly rising. This is the market trend of the week.
The TOPIX Global 250 index continued to fall, with main stocks bought and a steady movement compared to the Nikkei average.
Tokyo Stock Exchange Growth Market Index 826.36 -10.45 / volume 0.37122 billion shares / turnover 133.2 billion yen Tokyo Stock Exchange Growth Market 250 Index 640.56 -7.65 / volume 0.21897 billion shares / turnover 89.6 billion yen Today's Growth Market continues to decline with both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index. There are 139 gainers, 417 losers, and 28 no change. The US stock market continued to decline on the 24th. Dow Inc. fell 504.22 dollars (-1)
The TOPIX 250 index in the Tokyo Stock Exchange's Growth Market rebounded, with trading volume lower and the increase narrowing.
TOPIX Growth Market Index 851.07 +4.78 / Volume 0.2 billion 62.71 million shares / Trading value JPY 112.7 billion. TOPIX Growth Market 250 Index 660.90 +3.65 / Volume 0.1 billion 82.45 million shares / Trading value JPY 91.6 billion. Today's growth market saw increases in both the TOPIX Growth Market Index and TOPIX Growth Market 250 Index. Number of rising stocks was 317, number of falling stocks was 222, and unchanged stocks were 45. On the 22nd, the US stock market rebounded. The Dow rose 127.91 dollars (+0.
Pay attention to the movements of Biotechnology which fell sharply over the weekend and the battle of the 200-day moving average in the Growth 250 Index.
- Pay attention to whether the emerging markets can maintain the level of the 200-day moving average this week, which seems to be more stable than the prime market, which is shaken by former President Trump's words and actions. We want to pay attention to whether both the Tokyo Growth Market Index and the Tokyo Growth 250 Index can maintain the level of the 200-day moving average. Although the Russell 2000 index, which was a stimulus material for the current emerging markets, has stopped rising, we believe that the small and mid-cap stocks will continue to be strong in the US market compared to the major stock price indices such as NY Dow and Nasdaq. - Focus of buying
No Data